Amvis Holdings.Inc. (7071) AI Stock Analysis

• Market Cap: ¥51.32B
• Dividend Yield: 0.91%
• Average Volume (3M): 1.46M
• Price to Earnings (P/E): 15.0
• Beta (1Y): 1.16
• Revenue Growth: 15.77%
• EPS Growth: -50.57%
• Country: JP
• Employees: 4,046
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 11.09
• Shares Outstanding: 98,313,600
• 10 Day Avg. Volume: 829,320
• 30 Day Avg. Volume: 1,455,976
• PEG Ratio: -0.32
• Price to Book (P/B): 1.63
• Price to Sales (P/S): 1.19
• P/FCF Ratio: -13.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥484.00
• Price Target Upside: 2.11% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 26.17
• Revenue Forecast (FY): ¥52.10B

• Rating: 62 Neutral
• Price Target: ¥553.00 ▲(16.67% Upside)
• Action: Reiterated Date: 12/11/25
• Date: Action: Reiterated 12/11/25

Amvis Holdings Inc. receives a moderate score due to strong revenue growth but faces challenges with declining profit margins and liquidity issues. The technical indicators suggest a bearish trend, while the valuation appears reasonable. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Revenue Growth

Sustained top-line growth indicates underlying demand for Amvis's services and supports capacity expansion. For a care-services provider, steady revenue helps absorb fixed costs, fund incremental investments in facilities and staff, and underpins longer-term organic scale even if margins are under pressure.

Business Model & Market Position

Amvis operates essential, recurring healthcare services aimed at elderly and chronically ill patients. This defensive, needs-based business benefits from demographic aging and creates recurring revenue streams, high customer stickiness, and structural demand that should remain durable over the 2–6 month horizon.

Balanced Capital Structure

A stable equity ratio amid rising leverage signals that shareholders still hold meaningful capital cushions. This helps preserve borrowing capacity and financial flexibility to fund working capital or targeted investment, reducing short-term insolvency risk even as debt levels climb.

Negative Factors

Margin Compression

Material deterioration in gross and net margins points to sustained cost pressure or pricing weakness in core services. Lower profitability reduces internal cash available for reinvestment and debt servicing, and if structural, can impair returns on expansion and weaken resilience to demand shocks.

Rising Leverage

Elevated and rising leverage increases financial risk, raising interest burden and limiting strategic flexibility. In a regulated, capital-intensive care sector, higher debt constrains ability to pursue acquisitions or invest in quality improvements and magnifies the impact of any cash-flow volatility.

Negative Free Cash Flow / Liquidity

Persistent negative free cash flow and weak operating cash conversion indicate the company may rely on external financing for operations and growth. This elevates liquidity risk, could increase financing costs, and reduces capacity to deleverage or fund capital expenditures from internal sources.

Amvis Holdings.Inc. Business Overview & Revenue Model

Company Description

Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Amvis Holdings generates revenue through a multi-faceted model, primarily by acquiring stakes in high-potential companies within its sectors of interest. The company earns income through dividends from its investments, capital gains from the appreciation of its holdings, and fees for services rendered by its subsidiaries. Additionally, Amvis engages in strategic partnerships that allow for collaborative projects and shared resources, further enhancing its revenue streams. Its focus on technology and innovation positions it to capitalize on emerging market trends, which can lead to significant financial returns.

Amvis Holdings.Inc. Financial Statement Overview

Summary

Amvis Holdings Inc. shows strong revenue growth but faces declining profit margins and increasing leverage, raising concerns about financial health. Negative free cash flow trends highlight potential liquidity challenges.

Income Statement

Amvis Holdings Inc. has shown consistent revenue growth over the years, with a 5.29% increase in the latest year. However, margins have been declining, with the gross profit margin dropping from 40.16% to 30.07% and the net profit margin decreasing from 17.51% to 7.44%. This indicates pressure on profitability despite revenue growth.

Balance Sheet

The company's debt-to-equity ratio has increased to 1.11, indicating higher leverage, which could pose a risk if not managed properly. Return on equity has also decreased to 10.13%, reflecting reduced profitability on shareholders' equity. However, the equity ratio remains stable, suggesting a balanced capital structure.

Cash Flow

Amvis Holdings Inc. faces challenges with negative free cash flow, which has worsened over the years. The free cash flow to net income ratio is negative, indicating that the company is not generating enough cash to cover its net income. The operating cash flow to net income ratio is relatively low, suggesting potential liquidity issues.

Breakdown	TTM	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	46.70B	49.17B	42.48B	31.98B	23.07B	15.33B
Gross Profit	16.71B	14.79B	17.06B	13.27B	9.69B	6.30B
EBITDA	11.56B	9.02B	12.76B	10.39B	7.10B	4.48B
Net Income	6.33B	3.66B	7.44B	6.31B	4.28B	2.63B
Balance Sheet
Total Assets	82.68B	83.95B	71.80B	55.56B	41.77B	31.92B
Cash, Cash Equivalents and Short-Term Investments	11.81B	10.83B	8.87B	12.13B	11.34B	11.19B
Total Debt	40.32B	40.15B	31.75B	23.05B	17.43B	12.75B
Total Liabilities	47.52B	47.81B	38.59B	29.04B	21.31B	15.58B
Stockholders Equity	35.16B	36.13B	33.21B	26.52B	20.46B	16.34B
Cash Flow
Free Cash Flow	0.00	-4.38B	-8.52B	-3.06B	-2.73B	-2.79B
Operating Cash Flow	0.00	6.03B	7.48B	6.80B	4.42B	2.58B
Investing Cash Flow	0.00	-10.43B	-16.83B	-10.31B	-7.75B	-5.78B
Financing Cash Flow	0.00	6.37B	6.08B	4.30B	3.49B	11.05B

Amvis Holdings.Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 474.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Positive. The current price of 474 is below the 20-day moving average (MA) of 498.60, below the 50-day MA of 479.34, and below the 200-day MA of 513.97, indicating a bullish trend. The MACD of 7.07 indicates Negative momentum. The RSI at 60.82 is Neutral, neither overbought nor oversold. The STOCH value of 73.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7071.

Amvis Holdings.Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	75 Outperform	¥30.28B	17.64	―	2.48%	3.88%	0.31%
6099	72 Outperform	¥46.49B	16.80	20.29%	1.77%	16.49%	3.34%
6062	72 Outperform	¥47.48B	14.37	―	2.63%	0.30%	-31.28%
6197	68 Neutral	¥90.19B	20.67	―	2.47%	1.86%	1370.48%
9158	68 Neutral	¥29.29B	16.32	―	―	31.65%	-51.36%
7071	62 Neutral	¥51.32B	14.99	―	0.91%	15.77%	-50.57%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Amvis Holdings.Inc. Corporate Events

Amvis Issues Performance-Linked Stock Options to Drive Growth in Medical Support Business

Amvis Holdings has approved the issuance of paid stock acquisition rights as stock options to its directors and employees, aiming to boost motivation, align interests with shareholders, and support medium- to long-term growth in its comprehensive medical support business. The Sixth Series options will go to CEO Keiichi Shibahara, with exercise tied to performance and share price targets, plus a mandatory exercise clause if the share price falls below 50% of the exercise price to ensure shared downside risk and discourage actions that could depress the stock.

The Seventh Series options will be allotted to directors and employees, including 10,000 rights for Director Kosuke Saita, and are similarly linked to performance and share price goals but without a mandatory exercise condition. If fully exercised, the options would dilute existing shareholders by 2.55% of current shares, which the company views as a reasonable impact given the expected enhancement of corporate and shareholder value through greater equity ownership by management.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen491.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Major Shareholder Grants Call Options to Align Insiders With Long-Term Value

Amvis Holdings’ major shareholder, IDEA Capital Co., Ltd., wholly owned by CEO Keiichi Shibahara, has agreed to grant call options over up to 1.1 million Amvis shares to 16 eligible insiders, including directors and employees of the company and its wholly owned subsidiaries. These contracts are strictly between the shareholder and the individuals, and the company itself is not a party to the agreements.

The scheme is designed to better align management and employee interests with those of shareholders and to incentivize contributions to medium- to long-term corporate and shareholder value, mirroring the structure of Amvis’s recently issued paid stock options. Because the options will be satisfied using existing shares held by IDEA Capital rather than newly issued stock, the company emphasized that there will be no share dilution or impact on consolidated financial results.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen491.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Posts Q1 Sales Growth but Profit Declines, Keeps FY2026 Outlook and Dividend Plan

Amvis Holdings reported consolidated net sales of ¥12.94 billion for the first quarter ended December 31, 2025, up 9.9% year on year, while EBITDA and profit attributable to owners of parent declined 8.6% and 19.7% respectively, reflecting increased costs and margin pressure despite continued top-line growth. The balance sheet remained solid with total assets of ¥83.35 billion and a shareholders’ equity ratio of 44.2%, and the company kept its full-year forecast unchanged, projecting modest 5.1% sales growth but significantly lower profits, along with maintaining its dividend policy of no interim dividend and a year-end payout of ¥4 per share, signaling ongoing shareholder returns amid a profit downcycle.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen491.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Completes Treasury Share Disposal for Employee Restricted Stock Compensation

Amvis Holdings has completed the payment procedures for the disposal of 578,000 shares of its treasury stock as restricted share compensation to 22 employees of the company and its subsidiary, at a disposal price of 468 yen per share for a total of 270.5 million yen. This share-based compensation program is designed to align employee incentives with shareholder interests and strengthen retention by granting restricted shares, reflecting the company’s continued use of equity compensation as part of its human capital and governance strategy.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen491.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Outlines Plan to Restore Prime Market Tradable Share Ratio and Avoid Delisting Risk

Amvis Holdings has disclosed that, as of the end of September 2025, it has fallen below the Tokyo Stock Exchange Prime Market’s required tradable share ratio of 35%, reporting a ratio of 34.3% despite meeting all other quantitative listing criteria. The company has entered an improvement period running through September 30, 2026, during which it must restore compliance or risk its shares being placed under supervision and potentially delisted by April 1, 2027. Management attributes the shortfall mainly to low share liquidity caused by a high concentration of holdings among domestic corporate shareholders, management, and treasury stock, and while the CEO acknowledges improving the tradable share ratio as a priority, he prefers to focus on enhancing corporate value rather than selling his own shares into the market. As corrective measures, Amvis will grant 578,000 treasury shares as restricted stock to employees to foster an investor-oriented mindset and modestly raise the tradable share ratio, and it expects further improvement from reduced management shareholdings following organizational and personnel changes, targeting a return to the 35% threshold needed to maintain its Prime Market listing.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis to Grant ¥270 Million in Restricted Shares to Employees

Amvis Holdings, Inc. has approved the disposal of 578,000 treasury shares as new restricted shares to 22 employees of the company and its subsidiaries, at a price of 468 yen per share for a total of 270,504,000 yen, with a three-year transfer restriction period ending in February 2029. The restricted stock plan is designed to serve as a medium- to long-term incentive, promoting continuous service, enhancing the group’s corporate value, and reinforcing value sharing with shareholders, with detailed conditions governing transfer restrictions, forfeiture, and treatment in cases of leave, departure, or corporate reorganization, and a pay-in price set in line with the market closing price prior to board approval.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Clarifies Relationship With Controlling Shareholder IDEA Capital and Safeguards for Minority Investors

Amvis Holdings, Inc. disclosed that IDEA Capital holds 52.97% of its voting rights, formally identifying it as a controlling shareholder other than a parent company, and clarified that there are currently no significant transactions with this controlling shareholder. The company emphasized a governance policy that, in principle, avoids transactions with controlling shareholders, but where such dealings are necessary, they are subject to Board approval, arm’s-length conditions, and review by a special committee composed of outside directors and outside Audit & Supervisory Board members to protect minority shareholder interests and ensure fairness.

The most recent analyst rating on (JP:7071) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.